Here are the Form 4 insider transactions from Boston Scientific Corporation (BSX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BSX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BSX filings page.
Boston Scientific executive reports option exercises and share sale. An officer of Boston Scientific Corp. exercised multiple stock options on 12/01/2025, acquiring 17,313 shares of common stock at exercise prices ranging from $17.26 to $27.09 per share. On the same date, the executive sold 17,313 shares of common stock in an open-market transaction at a weighted average price of $101.5531 per share under a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024. After these transactions, the executive directly held 23,600 shares of Boston Scientific common stock and indirectly held 13,354 shares through the company’s 401(k) Retirement Savings Plan.
Boston Scientific Corp. insider activity shows the SVP and Chief HR Officer reporting a stock transfer. On 11/28/2025, the officer disposed of 260 shares of common stock in a transaction coded "G," which typically indicates a gift, at a reported price of $0.0000 per share. After this transaction, the officer directly owned 14,797 shares and indirectly owned 1,731 shares through a spouse. A footnote explains that the direct holdings include shares acquired on June 30, 2025 under the company’s Employee Stock Purchase Plan.